Boehringer Ingelheim’s weight-loss drug candidate survodutide could also be effective for liver disease metabolic dysfunction-associated steatohepatitis (MASH), if the results of a mid-stage ...

Novo Nordisk's GLP-1 receptor agonist semaglutide has shown efficacy as a treatment for metabolic dysfunction-associated steatohepatitis (MASH) in a phase 3 trial, potentially teeing up US and ...

A filmic companion to the Weeknd’s latest album, this meta psychological thriller is all style and no substance. By Brandon Yu A housewife’s domestic distresses take a horrifying turn in this ...

The news of the day as interpreted by our talented artists, illustrators and cartoonists.

You can find this story in My Bookmarks.Or by navigating to the user icon in the top right.